Literature DB >> 18470721

Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.

G Fleischhack1, D Cipic, J Juettner, C Hasan, U Bode.   

Abstract

OBJECTIVE: Sensitive parameters of inflammations, are rare or of limited validity in neutropenic patients. Procalcitonin (PCT) proven to be a sensitive inflammatory marker in nonneutropenic patients was evaluated for its diagnostic relevance in febrile episodes of neutropenic patients with cancer
METHODS: Plasma levels of PCT were determined by an immunoluminometric assay in children with febrile neutropenic episodes (n=376) starting at the date of admission until the resolution of fever and were correlated with serum levels of the C-reactive protein (CrP). Febrile episodes were classified as fever of unknown origin (FUO), microbiologically or clinically documented infections and were also differentiated according to the site of the infection (unknown, bacteremia, respiratory, soft tissue, gastrointestinal and urinary tract infection).
RESULTS: Independently from the aetiology and the site of infection the PCT peak value occurred mostly on the second hospital day and decreased rapidly in cases of successful antibiotic therapy and with the resolution of fever to the normal range (0.1+/-0.5 microg/l). The highest PCT peak levels at the onset of fever and during the febrile course were observed in patients with gramnegative bacteremia (n = 22, median 12.1 microg/l, range 0.4+/-568.2 microg/l). There was a positive correlation between PCT peak levels and CrP peak levels (r = 0.48, p = 0.001) which mostly were observed 24 h later than for PCT.
CONCLUSIONS: PCT is a sensitive and specific parameter in the diagnostic and in the sequential assessment of febrile neutropenic episodes, especially in gramnegative infections. Its diagnostic accuracy in neutropenic patients is clearly higher than that of CrP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 18470721     DOI: 10.1007/BF02900739

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  23 in total

1.  Measurement of procalcitonin levels in children with bacterial or viral meningitis.

Authors:  D Gendrel; J Raymond; M Assicot; F Moulin; J L Iniguez; P Lebon; C Bohuon
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

2.  Procalcitonin--influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations.

Authors:  M Meisner; K Tschaikowsky; S Schnabel; J Schmidt; A Katalinic; J Schüttler
Journal:  Eur J Clin Chem Clin Biochem       Date:  1997-08

3.  Procalcitonin: a new marker for differential diagnosis of acute rejection and bacterial infection in heart transplantation.

Authors:  M Staehler; C Hammer; B Meiser; B Reichart
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

4.  High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis.

Authors:  Y Gérard; D Hober; S Petitjean; M Assicot; C Bohuon; Y Mouton; P Wattré
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

5.  Procalcitonin in patients with and without immunosuppression and sepsis.

Authors:  B al-Nawas; P M Shah
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

6.  The differential diagnostic capacity of serum amyloid A protein between infectious and non-infectious febrile episodes of neutropenic patients with acute leukemia.

Authors:  M T Casl; B Rogina; I Glojnarić-Spasić; H Minigo; A Planinc-Peraica; B Jaksić
Journal:  Leuk Res       Date:  1994-09       Impact factor: 3.156

7.  Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia.

Authors:  A Engel; W V Kern; G Mürdter; P Kern
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

8.  Interleukin 8 in serum in granulocytopenic patients with infections.

Authors:  A Waage; D Remick; S Steinshamn; L Deforge; J Lamvik
Journal:  Br J Haematol       Date:  1994-01       Impact factor: 6.998

9.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

Review 10.  Procalcitonin--a new indicator of the systemic response to severe infections.

Authors:  W Karzai; M Oberhoffer; A Meier-Hellmann; K Reinhart
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

View more
  4 in total

1.  Procalcitonin--a marker of invasive fungal infection?

Authors:  H J Dornbusch; V Strenger; R Kerbl; H Lackner; W Schwinger; P Sovinz; C Urban
Journal:  Support Care Cancer       Date:  2005-01-19       Impact factor: 3.603

2.  Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia.

Authors:  Matjaz Jereb; Tadeja Kotar
Journal:  Wien Klin Wochenschr       Date:  2006-04       Impact factor: 1.704

Review 3.  Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia.

Authors:  Silvia Jiménez-Morales; Ivan Sammir Aranda-Uribe; Carlos Jhovani Pérez-Amado; Julian Ramírez-Bello; Alfredo Hidalgo-Miranda
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

4.  Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients.

Authors:  Yeter Düzenli Kar; Zeynep Canan Özdemir; Özcan Bör
Journal:  Turk Pediatri Ars       Date:  2017-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.